Chromosomal aberrations, particularly copy‐number variations (CNVs), are prevalent in neurodevelopmental disorders (NDD) and significantly contribute to their pathogenesis. Copy‐number gains (CN gains) in 15q11‐q13, primarily consisting of a pseudo (iso‐)dicentric chromosome 15 [(i)dic(15)] or an interstitial duplication, are among the most frequent CNVs in NDD. The associated Dup15q syndrome is an early onset neurodevelopmental disorder characterized by global developmental delay, behavioral issues, and seizures with a variable onset and expression of symptoms. While a correlation between the number of 15q11‐q13 CN gains and symptom severity has been proposed, it fails to fully explain the wide phenotypic variability observed. We conducted a comprehensive systematic literature‐based analysis of the supernumerary (i)dic(15), generating the largest literature‐based cohort consisting of patient‐level genotype data for Dup15q syndrome to date. Our findings identified symmetric BP3:BP3 and asymmetric BP4:BP5 (i)dic(15) configurations as the most common (i)dic(15) formations, likely arising from distinct mechanisms and potentially driving characteristic genotype–phenotype outcomes. Additionally, we identified a significant gap within the molecular characterization of (i)dic(15), particularly regarding information on nucleotide‐level breakpoints, genomic structure, and differentially imprinted genes, being important aspects for genotype–phenotype predictions. Our findings provide critical insight into the molecular architecture of (i)dic(15), offering valuable implications for understanding pathomechanisms and guidance for future research into the molecular and clinical aspects of Dup15q syndrome.
KCNQ1 encodes a voltage-gated potassium channel implicated in peripheral and neurological disorders, but its role in human neurodevelopment remains unclear. We generated KCNQ1 knockout (KO) human induced pluripotent stem cells and differentiated them into neural stem cells (NSCs) and cortical neurons. KCNQ1 -deficient NSCs show impaired neurite outgrowth, linked to reduced cell adhesion and disrupted neural cell adhesion molecule signalling, a phenotype reproduced by pharmacological KCNQ1 inhibition. Multi-omics and follow-up analyses reveal mitochondrial dysfunction, including reduced mitochondrial copy number and ATP synthase expression. KO cells also show impaired insulin signalling, with diminished insulin receptor gene expression and altered RAS-MAPK and PI3K-AKT pathways. In differentiated neuronal cultures, KCNQ1 loss decreases synaptic activity and maintains an immature transcriptional profile. Together, these findings identify a role for KCNQ1 in regulating cell adhesion, mitochondrial function, insulin signalling, and neuronal maturation, expanding our understanding of processes that may contribute to neurological manifestations associated with KCNQ1 -related disorders.